Shanghai HeartCare Medical Technology Past Earnings Performance
Past criteria checks 0/6
Shanghai HeartCare Medical Technology has been growing earnings at an average annual rate of 15.1%, while the Medical Equipment industry saw earnings growing at 14.7% annually. Revenues have been growing at an average rate of 42.7% per year.
Key information
15.1%
Earnings growth rate
28.8%
EPS growth rate
| Medical Equipment Industry Growth | 13.7% |
| Revenue growth rate | 42.7% |
| Return on equity | -4.2% |
| Net Margin | -17.8% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Even With A 42% Surge, Cautious Investors Are Not Rewarding Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) Performance Completely
Sep 27
Some Shareholders Feeling Restless Over Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) P/S Ratio
Aug 01We're Not Very Worried About Shanghai HeartCare Medical Technology's (HKG:6609) Cash Burn Rate
Jan 23Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely
Aug 30Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth
Aug 09Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth
May 07We're Hopeful That Shanghai HeartCare Medical Technology (HKG:6609) Will Use Its Cash Wisely
Nov 29Revenue & Expenses Breakdown
How Shanghai HeartCare Medical Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 251 | -45 | 140 | 86 |
| 31 Mar 24 | 242 | -69 | 147 | 105 |
| 31 Dec 23 | 232 | -94 | 154 | 124 |
| 30 Sep 23 | 224 | -141 | 160 | 143 |
| 30 Jun 23 | 216 | -188 | 165 | 163 |
| 31 Mar 23 | 199 | -194 | 167 | 158 |
| 31 Dec 22 | 183 | -200 | 168 | 154 |
| 30 Sep 22 | 160 | -185 | 155 | 129 |
| 30 Jun 22 | 137 | -169 | 142 | 105 |
| 31 Mar 22 | 115 | -188 | 146 | 92 |
| 31 Dec 21 | 90 | -194 | 135 | 76 |
| 30 Sep 21 | 66 | -242 | 176 | 75 |
| 30 Jun 21 | 43 | -290 | 217 | 73 |
| 31 Mar 21 | 28 | -244 | 179 | 60 |
| 31 Dec 20 | 15 | -214 | 156 | 51 |
Quality Earnings: 6609 is currently unprofitable.
Growing Profit Margin: 6609 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6609 is unprofitable, but has reduced losses over the past 5 years at a rate of 15.1% per year.
Accelerating Growth: Unable to compare 6609's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 6609 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-4.3%).
Return on Equity
High ROE: 6609 has a negative Return on Equity (-4.19%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/08 10:06 |
| End of Day Share Price | 2025/01/08 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shanghai HeartCare Medical Technology Corporation Limited is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jin Zhang | China International Capital Corporation Limited |
| Yuan Gao | China International Capital Corporation Limited |
| Chris Pan | Goldman Sachs |